ALAMEDA, Calif., Penumbra, Inc., a global interventional therapies company, today announced the U.S. launch of its new POD ® Packing Coil, designed to be used as a complementary device with Penumbra’s ...
"We've engineered Ruby XL to deliver more volume per coil than any other coil on the market, which may result in cost savings," said Shruthi Narayan, President of Interventional Business at Penumbra, ...
ALAMEDA, Calif.--(BUSINESS WIRE)--Today Penumbra, Inc. announced the US launch of the Penumbra Coil 400, a stretch-resistant, platinum embolic coil that has a 400% volume filling advantage compared to ...
Penumbra, Inc. PEN recently launched the Ruby XL System, the longest, largest and softest coil in the market, followed by its Food and Drug Administration (FDA) clearance. The Ruby XL System is ...
poses a challenge - Key market players include Abbott Laboratories, Achieva Medical, BALT Group, Boston Scientific Corp., Braile Biomedica, Cordis Corp., Cook Group ...
ALAMEDA, Calif., June 5, 2025 /PRNewswire/ -- Penumbra, Inc (PEN). (NYSE: PEN) announced the U.S. Food and Drug Administration (FDA) clearance and launch of the Ruby ® XL System, the longest, largest ...
NEW YORK, Oct. 11, 2024 /PRNewswire/ -- Report with the AI impact on market trends - The Global Embolization Coil Market size is estimated to grow by USD 538.3 million from 2024-2028, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results